메뉴 건너뛰기




Volumn 32, Issue 3, 2014, Pages 943-950

An ovarian cancer model with positive ER: Reversion of ER antagonist resistance by Src blockade

Author keywords

Fulvestrant; Ovarian cancer; Resistance; Saracatinib

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; PROTEIN P27; SARACATINIB; STEROID RECEPTOR COACTIVATOR 1; 1,3 BENZODIOXOLE DERIVATIVE; ANTINEOPLASTIC AGENT; ESTRADIOL; ESTROGEN RECEPTOR ANTAGONIST; PROTEIN TYROSINE KINASE; QUINAZOLINE DERIVATIVE;

EID: 84923068395     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3284     Document Type: Article
Times cited : (10)

References (35)
  • 3
    • 84868587857 scopus 로고    scopus 로고
    • Src inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo
    • Simpkins F, Hevia-Paez P, Sun J, et al: Src inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo. Clin Cancer Res 18: 5911-5923, 2012.
    • (2012) Clin Cancer Res , vol.18 , pp. 5911-5923
    • Simpkins, F.1    Hevia-Paez, P.2    Sun, J.3
  • 4
    • 84886098299 scopus 로고    scopus 로고
    • Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer
    • Argenta PA, Um I, Kay C, et al: Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer. Gynecol Oncol 131: 368-373, 2013.
    • (2013) Gynecol Oncol , vol.131 , pp. 368-373
    • Argenta, P.A.1    Um, I.2    Kay, C.3
  • 5
    • 84864477585 scopus 로고    scopus 로고
    • Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells
    • Badia E, Docquier A, Busson M, et al: Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells. J Steroid Biochem Mol Biol 132: 176-185, 2012.
    • (2012) J Steroid Biochem Mol Biol , vol.132 , pp. 176-185
    • Badia, E.1    Docquier, A.2    Busson, M.3
  • 6
    • 84866132321 scopus 로고    scopus 로고
    • Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer
    • Bossard C, Busson M, Vindrieux D, et al: Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer. PLoS One 7: e44787, 2012.
    • (2012) PLoS One , vol.7
    • Bossard, C.1    Busson, M.2    Vindrieux, D.3
  • 7
    • 80052713086 scopus 로고    scopus 로고
    • Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival
    • Halon A, Materna V, Drag-Zalesinska M, et al: Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival. Pathol Oncol Res 17: 511-518, 2011.
    • (2011) Pathol Oncol Res , vol.17 , pp. 511-518
    • Halon, A.1    Materna, V.2    Drag-Zalesinska, M.3
  • 8
    • 78649496224 scopus 로고    scopus 로고
    • Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: A case report and review of the literature
    • Kothari R, Argenta P, Fowler J, Carter J and Shimp W: Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: a case report and review of the literature. Arch Oncol 18: 32-35, 2010.
    • (2010) Arch Oncol , vol.18 , pp. 32-35
    • Kothari, R.1    Argenta, P.2    Fowler, J.3    Carter, J.4    Shimp, W.5
  • 10
    • 84873430440 scopus 로고    scopus 로고
    • Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models
    • Park MA, Hwang KA, Lee HR, Yi BR, Jeung EB and Choi KC: Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models. Toxicology 305: 41-48, 2013.
    • (2013) Toxicology , vol.305 , pp. 41-48
    • Park, M.A.1    Hwang, K.A.2    Lee, H.R.3    Yi, B.R.4    Jeung, E.B.5    Choi, K.C.6
  • 11
    • 84883428665 scopus 로고    scopus 로고
    • Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression
    • Wang L, Wang G, Yang D, et al: Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression. Mol Med Rep 8: 1279-1285, 2013.
    • (2013) Mol Med Rep , vol.8 , pp. 1279-1285
    • Wang, L.1    Wang, G.2    Yang, D.3
  • 12
    • 84921366824 scopus 로고    scopus 로고
    • Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro
    • [Epub ahead of print]
    • Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro. Breast Cancer 2013 [Epub ahead of print].
    • (2013) Breast Cancer
    • Jiang, D.1    Wang, X.2    Liu, X.3    Li, F.4
  • 15
    • 18744407590 scopus 로고    scopus 로고
    • A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance
    • DOI 10.1073/pnas.0502256102
    • Xing D and Orsulic S: A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathwaytargeted therapy and tumor resistance. Proc Natl Acad Sci USA 102: 6936-6941, 2005. (Pubitemid 40675420)
    • (2005) Proceedings of the National Academy of Sciences of the United States of America , vol.102 , Issue.19 , pp. 6936-6941
    • Xing, D.1    Orsulic, S.2
  • 16
    • 79959838081 scopus 로고    scopus 로고
    • Integrated genomic analyses of ovarian carcinoma
    • Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615, 2011.
    • (2011) Nature , vol.474 , pp. 609-615
  • 17
  • 18
    • 79953319793 scopus 로고    scopus 로고
    • Functional roles of Src and Fgr in ovarian carcinoma
    • Kim HS, Han HD, Armaiz-Pena GN, et al: Functional roles of Src and Fgr in ovarian carcinoma. Clin Cancer Res 17: 1713-1721, 2011.
    • (2011) Clin Cancer Res , vol.17 , pp. 1713-1721
    • Kim, H.S.1    Han, H.D.2    Armaiz-Pena, G.N.3
  • 20
    • 84859889324 scopus 로고    scopus 로고
    • EMT phenotype is induced by increased Src kinase activity via Src-mediated caspase-8 phosphorylation
    • Zhao Y, Li X, Sun X, Zhang Y and Ren H: EMT phenotype is induced by increased Src kinase activity via Src-mediated caspase-8 phosphorylation. Cell Physiol Biochem 29: 341-352, 2012.
    • (2012) Cell Physiol Biochem , vol.29 , pp. 341-352
    • Zhao, Y.1    Li, X.2    Sun, X.3    Zhang, Y.4    Ren, H.5
  • 21
    • 84869495012 scopus 로고    scopus 로고
    • Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells
    • Castoria G, Giovannelli P, Lombardi M, et al: Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. Oncogene 31: 4868-4877, 2012.
    • (2012) Oncogene , vol.31 , pp. 4868-4877
    • Castoria, G.1    Giovannelli, P.2    Lombardi, M.3
  • 23
    • 84876207386 scopus 로고    scopus 로고
    • The role of hormonal factors and endocrine therapy in ovarian cancer
    • Serkies K, Sinacki M and Jassem J: The role of hormonal factors and endocrine therapy in ovarian cancer. Contemp Oncol 17: 14-19, 2013.
    • (2013) Contemp Oncol , vol.17 , pp. 14-19
    • Serkies, K.1    Sinacki, M.2    Jassem, J.3
  • 24
    • 84874980133 scopus 로고    scopus 로고
    • Stem cells: Anatomy of an ovarian cancer
    • Brenton JD and Stingl J: Stem cells: anatomy of an ovarian cancer. Nature 495: 183-184, 2013.
    • (2013) Nature , vol.495 , pp. 183-184
    • Brenton, J.D.1    Stingl, J.2
  • 26
    • 81255157751 scopus 로고    scopus 로고
    • Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: The BIG 1-98 randomised clinical trial at 8.1 years median follow-up
    • Regan MM, Neven P, Giobbie-Hurder A, et al: Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up. Lancet Oncol 12: 1101-1108, 2011.
    • (2011) Lancet Oncol , vol.12 , pp. 1101-1108
    • Regan, M.M.1    Neven, P.2    Giobbie-Hurder, A.3
  • 27
    • 79955863530 scopus 로고    scopus 로고
    • Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src
    • Jung J, Kim HY, Kim M, Sohn K, Kim M and Lee K: Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src. Oncogene 30: 2264-2274, 2011.
    • (2011) Oncogene , vol.30 , pp. 2264-2274
    • Jung, J.1    Kim, H.Y.2    Kim, M.3    Sohn, K.4    Kim, M.5    Lee, K.6
  • 28
    • 68049094943 scopus 로고    scopus 로고
    • Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells
    • Hui AY, Meens JA, Schick C, et al: Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells. J Cell Biochem 107: 1168-1181, 2009.
    • (2009) J Cell Biochem , vol.107 , pp. 1168-1181
    • Hui, A.Y.1    Meens, J.A.2    Schick, C.3
  • 29
    • 77953405023 scopus 로고    scopus 로고
    • ErbB-inhibitory protein: A modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells
    • Nautiyal J, Yu Y, Aboukameel A, et al: ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells. Mol Cancer Ther 9: 1503-1514, 2010.
    • (2010) Mol Cancer Ther , vol.9 , pp. 1503-1514
    • Nautiyal, J.1    Yu, Y.2    Aboukameel, A.3
  • 30
    • 77952114407 scopus 로고    scopus 로고
    • Development of candidate genomic markers to select breast cancer patients for dasatinib therapy
    • Moulder S, Yan K, Huang F, et al: Development of candidate genomic markers to select breast cancer patients for dasatinib therapy. Mol Cancer Ther 9: 1120-1127, 2010.
    • (2010) Mol Cancer Ther , vol.9 , pp. 1120-1127
    • Moulder, S.1    Yan, K.2    Huang, F.3
  • 31
    • 84855748821 scopus 로고    scopus 로고
    • Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer
    • Gucalp A, Sparano JA, Caravelli J, et al: Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer. Clin Breast Cancer 11: 306-311, 2011.
    • (2011) Clin Breast Cancer , vol.11 , pp. 306-311
    • Gucalp, A.1    Sparano, J.A.2    Caravelli, J.3
  • 32
    • 77955760833 scopus 로고    scopus 로고
    • Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer
    • Arcaroli JJ, Touban BM, Tan AC, et al: Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer. Clin Cancer Res 16: 4165-4177, 2010.
    • (2010) Clin Cancer Res , vol.16 , pp. 4165-4177
    • Arcaroli, J.J.1    Touban, B.M.2    Tan, A.C.3
  • 33
    • 84880376355 scopus 로고    scopus 로고
    • Emerging regulation and functions of autophagy
    • Boya P, Reggiori F and Codogno P: Emerging regulation and functions of autophagy. Nat Cell Biol 15: 713-720, 2013.
    • (2013) Nat Cell Biol , vol.15 , pp. 713-720
    • Boya, P.1    Reggiori, F.2    Codogno, P.3
  • 34
    • 84877628647 scopus 로고    scopus 로고
    • Autophagy in human health and disease
    • Choi AM, Ryter SW and Levine B: Autophagy in human health and disease. N Engl J Med 368: 651-662, 2013.
    • (2013) N Engl J Med , vol.368 , pp. 651-662
    • Choi, A.M.1    Ryter, S.W.2    Levine, B.3
  • 35
    • 84880302335 scopus 로고    scopus 로고
    • Ambra1 at the crossroad between autophagy and cell death
    • Fimia GM, Corazzari M, Antonioli M and Piacentini M: Ambra1 at the crossroad between autophagy and cell death. Oncogene 32: 3311-3318, 2013.
    • (2013) Oncogene , vol.32 , pp. 3311-3318
    • Fimia, G.M.1    Corazzari, M.2    Antonioli, M.3    Piacentini, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.